Wird geladen...
Management of hormone-receptor positive human epidermal receptor 2 negative advanced or metastatic breast cancers
Hormone therapy, rather than chemotherapy, is recommended for hormone-receptor positive (HR+), human epidermal receptor 2 negative (HER2−) advanced or metastatic breast cancer (A/MBC) according to the European Society of Medical Oncology (ESMO), American Society of Clinical Oncology (ASCO) and Natio...
Gespeichert in:
| Veröffentlicht in: | Ann Transl Med |
|---|---|
| 1. Verfasser: | |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
AME Publishing Company
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6068330/ https://ncbi.nlm.nih.gov/pubmed/30105234 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2018.06.11 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|